Eleven Biotherapeutics, Inc.(EBIO)- NASDAQ
Company Description
Eleven Biotherapeutics, Inc. is a preclinical stage biopharmaceutical company with a proprietary protein engineering platform, called AMP-Rx, that it apply to the discovery and development of protein therapeutics to treat diseases of the eye. Its therapeutic approach is based on the role of... More
Sector: Healthcare
Industry: Biotechnology
Country: United States